INFORMATION:
Original Publication:
Ute Fischer et al. Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options. 27 July, 2015. Nature Genetics. doi: 10.1038/ng.3362.
About Alacris Theranostics GmbH
Berlin-based Alacris Theranostics, a spin-off company from the Max Planck Institute for Molecular Genetics, develops new approaches in personalized medicine for cancer patient diagnosis, treatment and drug stratification. The company uses its systems biology modelling platform ModCellTM to generate a "Virtual Patient" model, based on genome and transcriptome data, obtained by next generation sequencing, alongside information on complex pathways and from mutation and drug databases. The "Virtual Patient" model can predict the effects of drug treatment as well as optimized combinatory treatments to provide the means for truly personalized medicine approaches. In addition, Alacris' "Virtual Clinical Trial" system enables the in silico analysis of drug effects on patient cohorts, thus identifying stratified patient groups with particular genetic and molecular profiles that could be targeted by a drug to allow more efficient drug development and approval.
Contact:
Alacris Theranostics GmbH
Dr Bodo Lange, CEO
Fabeckstrasse 60-62
D-14195 Berlin
Germany
Phone: + 49 30 8431 22 510
Email: info@alacris.de
www.alacris.de
MC Services AG
Anne Hennecke, Managing Partner
Tel.: +49 211 529 252 22
Email: anne.hennecke@mc-services.eu END
Basis for new treatment options for a fatal leukemia in children revealed
Detailed molecular analyses allow new insights into the function of tumor cells and options for new treatments
2015-07-29
(Press-News.org) Berlin, 29th July 2015 - Acute lymphoblastic leukemia (ALL) is the most common type of cancer in children. It can occur in various forms, differing not only by specific changes in the genetic material of the leukemia cells but also by their response to therapies. Now, an international team of scientists from Berlin, Düsseldorf, Hannover, Heidelberg, Kiel, and Zurich have succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukemia, paving the way for new therapeutic approaches. Their results have been published in the current issue of the journal Nature Genetics (27 July).
Although intensive research over the last decade has significantly improved the survival rates of children suffering from ALL, a subset of patients remains resistant to treatment. One example is the very aggressive and incurable subtype associated with a t(17;19) chromosomal translocation, which occurs due to breakage and aberrant fusion of genetic material in the tumor cells, resulting in the formation of a new oncogenic protein encoded by the genes TCF3 and HLF (TCF3-HLF-positive leukemia cells). Until now, the molecular basis of this phenotype has remained elusive. An international group of clinicians and scientists from different universities and research institutions, with contributions from the Berlin-based company Alacris Theranostics GmbH, has conducted an in-depth analysis of the molecular features of the t(17; 19) ALL subtype.
The consortium team decoded the genome of the leukemic cells using sophisticated bioinformatics methods. The team found genetic aberrations in addition to the known translocation. "We are glad that we could contribute to this important project with genomic data analysis of leukemia cells to unravel some of the molecular changes in this disease", says Bodo Lange (CEO, Alacris Theranostics). With the aim of identifying therapeutic entry points for this incurable form of ALL, the transcriptome of the cancer cells was also analyzed in great detail, enabling identification of the genes active within the leukemic cell. The so-called expression profile of the cancer cells was deciphered by means of RNAseq, a focus of research in Marie-Laure Yaspo's group at the Max Planck Institute for Molecular Genetics in Berlin. The interplay between the fused TCF3-HLF oncogenic protein, additional DNA changes and altered gene expression program leads to a re-programming of leukemic cells to an early, stem-cell like developmental stage, although the phenotypic appearance of the cells remains similar. "This technique provides a quantitative read out of the actual genetic program occurring in the cancer cells, which allowed us to uncover relevant molecular mechanisms cooperating to promote tumorigenesis, and to identify possible druggable targets. These findings could only be achieved through analysis of the messenger RNAs", says Marie-Laure Yaspo.
In tandem, researchers from the team of Jean-Pierre Bourquin (University Children's Hospital, Zürich) transplanted the leukemic cells in mice and established a "humanized mouse model", an invaluable tool for testing therapeutic response. The consortium team demonstrated that the mouse engrafted and expanded cells retained most of the genetic features and expression profiles of the original leukemic cells. The cells thus behaved in a similar manner than in the patient, offering an attractive possibility for translational medicine. The Zurich Group tested close to hundred drugs, and demonstrated a very positive response of the mouse model TCF3-HLF-positive cells to Venetoclax, a drug targeting the protein BCL2, and which has already showed efficiency in other type of cancers.
The results of this study show the strong potential of coordinated research between an international consortium and the use of new technologies for advancing cancer research. This project was made possible through the shared contribution of the research teams from Jean-Pierre Bourquin, University Children's Hospital Zürich, Martin Stanulla, Hannover Medical School, Arndt Borkhardt, Heinrich-Heine University, Düsseldorf, Jan Korbel, European Molecular Biology Laboratory (EMBL), Heidelberg, Andre Franke, Christian-Albrechts-University Kiel, and Marie-Laure Yaspo at the Max Planck Institute for Molecular Genetics in Berlin. Contributions to the genomic data analysis of leukemic cells came from the Berlin-based company Alacris Theranostics. The project was funded by the German Federal Office for Radiation Protection via the environmental research program of the German Federal Environment Ministry and by the Swiss National Science Foundation (SNF).
ELSE PRESS RELEASES FROM THIS DATE:
Social groups and emotions
2015-07-29
Politicians, children, teachers, Europeans... what do they have in common? As discovered in a study led by Luca Piretti and his colleagues from SISSA (International School for Advanced Studies) of Trieste, they are all social groups, a special semantic category for the human brain that is closely linked with emotions.
Until recently, most neuroscientists believed that the representation of knowledge in the brain was based on two distinct systems: one involved in representing animate objects (or, generally, anything organic), and the other for representing inanimate objects ...
Alcohol laws have a preventive effect on young men
2015-07-29
When they reach for the glass, they often know no limits: Hazardous drinking is fairly common among young Swiss men. The good news: Based on a survey of around 5,700 young Swiss men with a mean age of 20, scientists from the University of Zurich reveal that legal regulations - such as the minimum legal drinking age and restrictions on the sale or advertising of alcoholic beverages - have a preventive effect on young consumers.
Around half of the respondents are high-risk drinkers, which means they consume at least six or more alcoholic drinks in a single session every ...
Overcoming why a new treatment is resisted by lung cancer
2015-07-29
A promising agent for the treatment of cancer has so far had little effect on the most common lung tumours, but new research from The University of Manchester has suggested how this resistance might be overcome.
In two papers released in the journal PNAS, the research team examined factors which mean that the most common type of lung cancer - itself the most common cause of cancer deaths - is resistant to a cytokine called TRAIL that causes cell death in many other types of tumour.
The researchers found that in non-small cell lung cancer, which accounts for around 85 ...
Study finds brain chemicals that keep wakefulness in check
2015-07-29
Mice that have a particular brain chemical switched off become hyperactive and sleep for just 65 per cent of their normal time.
This discovery, published in the journal Neuron, could help researchers to develop new drugs that promote better sleep, or control hyperactivity in people with the medical condition mania.
Scientists altered the neurochemistry of mice to help investigate why we need to sleep, what controls our wakefulness, and how a balance between these two states influences brain functions like concentration and memory and our general health.
The chemicals ...
Study of birds' sense of smell reveals important clues for behavior and adaptation
2015-07-29
From slight sparrows to preening peacocks to soaring falcons, birds have long been known to possess distinct abilities in their sense of smell, but little has been known about the evolution of olfaction.
Now, a large comparative genomic study of the olfactory genes tied to a bird's sense of smell has revealed important differences that correlate with their ecological niches and specific behaviors.
Authors Agostinho Antunes et al., in a new study published in the advanced online edition of Molecular Biology and Evolution, analyzed olfactory receptor genes (OR gene ...
York scientists unlock secrets of stars through aluminium
2015-07-29
Physicists at the University of York have revealed a new understanding of nucleosynthesis in stars, providing insight into the role massive stars play in the evolution of the Milky Way and the origins of the Solar System.
Radioactive aluminium (aluminium-26, or Al26) is an element that emits gamma radiation through its decay enabling astronomers to image its location in our galaxy. Studying how Al26 is created in massive stars, scientists have distinguished between previously conflicting assumptions about its rate of production by nuclear fusion.
Funded by the Science ...
Stressed out plants send animal-like signals
2015-07-29
University of Adelaide research has shown for the first time that, despite not having a nervous system, plants use signals normally associated with animals when they encounter stress.
Published today in the journal Nature Communications, the researchers at the Australian Research Council (ARC) Centre of Excellence in Plant Energy Biology reported how plants respond to their environment with a similar combination of chemical and electrical responses to animals, but through machinery that is specific to plants.
"We've known for a long-time that the animal neurotransmitter ...
Coffee consumption habits impact the risk of mild cognitive impairment
2015-07-28
Bari, Italy, July 28, 2015 -- A new study by researchers at the University of Bari Aldo Moro, Bari, Italy, Geriatric Unit & Laboratory of Gerontology and Geriatrics, IRCCS "Casa Sollievo della Sofferenza", San Giovanni Rotondo, Foggia, Italy, and Istituto Superiore di Sanità (ISS), Roma, Italy, estimates the association between change or constant habits in coffee consumption and the incidence of mild cognitive impairment (MCI), evaluating 1,445 individuals recruited from 5,632 subjects, aged 65-84 year old, from the Italian Longitudinal Study on Aging (ILSA), a population-based ...
Controlling phase changes in solids
2015-07-28
Rewritable CDs, DVDs and Blu-Ray discs owe their existence to phase-change materials, those materials that change their internal order when heated and whose structures can be switched back and forth between their crystalline and amorphous phases. Phase-change materials have even more exciting applications on the horizon, but our limited ability to precisely control their phase changes is a hurdle to the development of new technology.
One of the most popular and useful phase-change materials is GST, which consists of germanium, antimony, and tellurium. This material is ...
Use of cell-free microRNA as potential cancer biomarkers made possible through Droplet Digital™ PCR
2015-07-28
Hercules, CA -- July 28, 2015 -- Droplet Digital PCR (ddPCR™) has been shown to be a useful tool for the identification of microRNAs (miRNA) circulating in the blood that could serve as potential cancer biomarkers. A study in the journal Oncotarget further supports these findings and identifies a novel miRNA that shows great potential for breast cancer diagnosis. These findings confirm the potential clinical utility of ddPCR technology to precisely and reliably quantify cell-free miRNAs. The study also emphasizes that sample type as well as its preparation are critical ...
LAST 30 PRESS RELEASES:
Singles differ in personality traits and life satisfaction compared to partnered people
President Biden signs bipartisan HEARTS Act into law
Advanced DNA storage: Cheng Zhang and Long Qian’s team introduce epi-bit method in Nature
New hope for male infertility: PKU researchers discover key mechanism in Klinefelter syndrome
Room-temperature non-volatile optical manipulation of polar order in a charge density wave
Coupled decline in ocean pH and carbonate saturation during the Palaeocene–Eocene Thermal Maximum
Unlocking the Future of Superconductors in non-van-der Waals 2D Polymers
Starlight to sight: Breakthrough in short-wave infrared detection
Land use changes and China’s carbon sequestration potential
PKU scientists reveals phenological divergence between plants and animals under climate change
Aerobic exercise and weight loss in adults
Persistent short sleep duration from pregnancy to 2 to 7 years after delivery and metabolic health
Kidney function decline after COVID-19 infection
Investigation uncovers poor quality of dental coverage under Medicare Advantage
Cooking sulfur-containing vegetables can promote the formation of trans-fatty acids
How do monkeys recognize snakes so fast?
Revolutionizing stent surgery for cardiovascular diseases with laser patterning technology
Fish-friendly dentistry: New method makes oral research non-lethal
Call for papers: 14th Asia-Pacific Conference on Transportation and the Environment (APTE 2025)
A novel disturbance rejection optimal guidance method for enhancing precision landing performance of reusable rockets
New scan method unveils lung function secrets
Searching for hidden medieval stories from the island of the Sagas
Breakthrough study reveals bumetanide treatment restores early social communication in fragile X syndrome mouse model
Neuroscience leader reveals oxytocin's crucial role beyond the 'love hormone' label
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
[Press-News.org] Basis for new treatment options for a fatal leukemia in children revealedDetailed molecular analyses allow new insights into the function of tumor cells and options for new treatments